P Jeanteur

1.5k total citations
19 papers, 1.3k citations indexed

About

P Jeanteur is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, P Jeanteur has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Genetics. Recurrent topics in P Jeanteur's work include RNA Research and Splicing (5 papers), Cancer-related Molecular Pathways (3 papers) and Genetic factors in colorectal cancer (2 papers). P Jeanteur is often cited by papers focused on RNA Research and Splicing (5 papers), Cancer-related Molecular Pathways (3 papers) and Genetic factors in colorectal cancer (2 papers). P Jeanteur collaborates with scholars based in France. P Jeanteur's co-authors include Charles Theillet, Marc Piechaczyk, Jalila Adnane, Patrick Gaudray, Jean‐Pierre Molès, Daniel Birnbaum, Nadir Mechti, Jean Marie Blanchard, Christian Dani and Bernard Lebleu and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

P Jeanteur

19 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Jeanteur France 12 872 483 232 205 124 19 1.3k
G Vande Woude United States 13 964 1.1× 245 0.5× 142 0.6× 202 1.0× 98 0.8× 15 1.5k
P Jeanteur France 14 1.1k 1.2× 387 0.8× 196 0.8× 289 1.4× 85 0.7× 22 1.5k
Allen Coleman United States 15 840 1.0× 473 1.0× 153 0.7× 228 1.1× 51 0.4× 23 1.3k
Lucia Beviglia United States 13 708 0.8× 612 1.3× 267 1.2× 194 0.9× 160 1.3× 27 1.3k
Nelson Ellmore United States 9 647 0.7× 359 0.7× 117 0.5× 132 0.6× 115 0.9× 11 1.0k
T Blunt United Kingdom 10 1.7k 1.9× 597 1.2× 382 1.6× 182 0.9× 103 0.8× 10 2.1k
Alessandra Gentile Italy 16 618 0.7× 316 0.7× 140 0.6× 168 0.8× 92 0.7× 28 1.0k
Karl-Heinz Klempnauer Germany 14 1.4k 1.6× 474 1.0× 396 1.7× 446 2.2× 134 1.1× 19 2.1k
Xiantuo Wu United States 10 1.4k 1.6× 365 0.8× 248 1.1× 240 1.2× 121 1.0× 10 1.6k
Peter Scully United States 7 1.1k 1.3× 1.4k 2.8× 266 1.1× 443 2.2× 164 1.3× 8 2.0k

Countries citing papers authored by P Jeanteur

Since Specialization
Citations

This map shows the geographic impact of P Jeanteur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Jeanteur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Jeanteur more than expected).

Fields of papers citing papers by P Jeanteur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Jeanteur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Jeanteur. The network helps show where P Jeanteur may publish in the future.

Co-authorship network of co-authors of P Jeanteur

This figure shows the co-authorship network connecting the top 25 collaborators of P Jeanteur. A scholar is included among the top collaborators of P Jeanteur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Jeanteur. P Jeanteur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Tazi, Jamal, Sébastien Durand, & P Jeanteur. (2005). The spliceosome: a novel multi-faceted target for therapy. Trends in Biochemical Sciences. 30(8). 469–478. 48 indexed citations
2.
Jeanteur, P & Jamal Tazi. (2005). Le code de l’épissage et sa modulation thérapeutique par des molécules chimiques. médecine/sciences. 21(10). 793–795. 4 indexed citations
3.
Jeanteur, P. (2000). [14-3-3sigma (stratifin), a potential tumor suppressor frequently inactivated by methylation in cancer of the breast].. PubMed. 87(7-8). 525–525. 2 indexed citations
4.
Jeanteur, P. (1998). [Acute promyelocytic leukemia, histone deacetylase, and response to retinoids].. PubMed. 85(4). 301–3. 1 indexed citations
5.
Jeanteur, P. (1998). [From dendritic cells to the exosomes that they secrete: a decisive advance for anticancer vaccine therapy?].. PubMed. 85(6). 521–521. 1 indexed citations
6.
Jeanteur, P. (1998). [The role of APC in colonic cancerogenesis: zeroing in on Myc].. PubMed. 85(11). 925–8. 6 indexed citations
7.
Molès, Jean‐Pierre, et al.. (1993). p53 gene mutations in human epithelial skin cancers.. PubMed. 8(3). 583–8. 154 indexed citations
8.
Vincent, Sylvie, L. Marty, Lionel Le Gallic, P Jeanteur, & Philippe Fort. (1993). Characterization of late response genes sequentially expressed during renewed growth of fibroblastic cells.. PubMed. 8(6). 1603–10. 17 indexed citations
9.
Plet, Ariane, et al.. (1992). In vivo footprints between the murine c-myc P1 and P2 promoters.. PubMed. 7(9). 1847–51. 10 indexed citations
10.
Portier, M, Jean‐Pierre Molès, P Jeanteur, et al.. (1992). p53 and RAS gene mutations in multiple myeloma.. PubMed. 7(12). 2539–43. 120 indexed citations
11.
Adnane, Jalila, Patrick Gaudray, Gregg Crumley, et al.. (1991). BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers.. PubMed. 6(4). 659–63. 201 indexed citations
12.
Roux, Pierre, Jean‐Marie Blanchard, Anne Fernandez, et al.. (1990). Nuclear localization of c-Fos, but not v-Fos proteins, is controlled by extracellular signals. Cell. 63(2). 341–351. 161 indexed citations
13.
Brouillet, Jean‐Paul, Charles Theillet, Thierry Maudelondé, et al.. (1990). Cathepsin D assay in primary breast cancer and lymph nodes: Relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness. European Journal of Cancer and Clinical Oncology. 26(4). 437–441. 75 indexed citations
14.
Bonnieu, Anne, Pierre‐François Roux, L. Marty, P Jeanteur, & Marc Piechaczyk. (1990). AUUUA motifs are dispensable for rapid degradation of the mouse c-myc RNA.. PubMed. 5(10). 1585–8. 35 indexed citations
15.
Theillet, Charles, Jalila Adnane, Pierre Szepetowski, et al.. (1990). BCL-1 participates in the 11q13 amplification found in breast cancer.. PubMed. 5(1). 147–9. 73 indexed citations
16.
Adnane, Jalila, Patrick Gaudray, Marie‐Pierre Simon, et al.. (1990). Proto-oncogene amplification and human breast tumor phenotype. Trends in Genetics. 6(11). 4–4. 134 indexed citations
17.
Dani, Christian, Nadir Mechti, Marc Piechaczyk, et al.. (1985). Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells.. Proceedings of the National Academy of Sciences. 82(15). 4896–4899. 175 indexed citations
18.
Cathala, Guy, Jocelyne Rech, Janine Huet, & P Jeanteur. (1979). Isolation and characterization of two types of ribonucleases H in Krebs II ascites cells.. Journal of Biological Chemistry. 254(15). 7353–7361. 31 indexed citations
19.
Croissant, O, C. Dauguet, P Jeanteur, & Gérard Orth. (1972). [Application of the molecular hybridization technic in situ for the demonstration with the electron microscope, of vegetative replication of viral DNA in the papillomas induced with Shope virus in cottontail rabbits].. PubMed. 274(4). 614–7. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026